The Annals Visit the PharmaCE website!
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 30, No. 12, pp. 1446-1451.
© 1996 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gidal, B.
Right arrow Articles by Graves, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gidal, B.
Right arrow Articles by Graves, N.

Research Articles

Current developments in neurology, Part II: Advances in the pharmacotherapy of Alzheimer disease, Parkinson's disease, and stroke

BE Gidal, ML Crismon, ML Wagner, SC Fagan, MD Privitera, C Dalmady-Israel, and NM Graves

Disorders of the central nervous system provide innumerable challenges to the clinician. Often the underlying pathophysiology is not completely understood, thus preventing the design of treatment strategies aimed at correcting the underlying process. In this decade of the brain, basic science research combined with difficult but necessary clinical trials may answer some of these seemingly over-whelming questions for these devastating illnesses.


This article has been cited by other articles:


Home page
 Research on Social Work PracticeHome page
J. T. Callaway
Psychopharmacological Treatment of Dementia
Research on Social Work Practice, July 1, 1998; 8(4): 452 - 474.
[Abstract] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 1996 by Harvey Whitney Books Company.